Evalution of the granisetron instead of ondansetron in the emergency room
Phase 1
- Conditions
- ausea and vomiting.Nausea and vomiting
- Registration Number
- IRCT20230726058930N3
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Nausea
Vomit
Exclusion Criteria
Patients with symptoms such as headaches, lateralized symptoms, and unstable vital signs.
Patients who have chest pain or ECG changes.
Patients with symptoms of Rise ICP.
Patients who have used drugs that increase serotonin (such as fluoxetine, doxepin, isomerbuxazid, amitriptyline, etc.) in the last few days.
Patients who have used drugs that increase serotonin (such as fluoxetine, doxepin, isomerbuxazid, amitriptyline, etc.) in the last few days.
Patients who have consumed grapefruit in the past 24 hours Patient does not consent to attend or continue treatment.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: 30, 15, 45, 60, 75 and 95 minutes after intravenous granisetron injection. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method